| EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. | |
| | |
MedLine Citation:
|
PMID: 19772513 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This guideline, together with its sister guideline on the classification of urticaria (Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64: 1417-1426), is the result of a consensus reached during a panel discussion at the Third International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO). As members of the panel, the authors had prepared their suggestions regarding management of urticaria before the meeting. The draft of the guideline took into account all available evidence in the literature (including Medline and Embase searches and hand searches of abstracts at international allergy congresses in 2004-2008) and was based on the existing consensus reports of the first and the second symposia in 2000 and 2004. These suggestions were then discussed in detail among the panel members and with the over 200 international specialists of the meeting to achieve a consensus using a simple voting system where appropriate. Urticaria has a profound impact on the quality of life and effective treatment is, therefore, required. The recommended first line treatment is new generation, nonsedating H(1)-antihistamines. If standard dosing is not effective, increasing the dosage up to four-fold is recommended. For patients who do not respond to a four-fold increase in dosage of nonsedating H(1)-antihistamines, it is recommended that second-line therapies should be added to the antihistamine treatment. In the choice of second-line treatment, both their costs and risk/benefit profiles are most important to consider. Corticosteroids are not recommended for long-term treatment due to their unavoidable severe adverse effects. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). |
| | |
Authors:
|
T Zuberbier; R Asero; C Bindslev-Jensen; G Walter Canonica; M K Church; A M Giménez-Arnau; C E H Grattan; A Kapp; M Maurer; H F Merk; B Rogala; S Saini; M Sánchez-Borges; P Schmid-Grendelmeier; H Schünemann; P Staubach; G A Vena; B Wedi; ; ; ; |
Related Documents
:
|
16849293 - Veterinary specialization in europe. 12488593 - Picking some news about the retroviral vector world from the 9th symposium of the europ... 12796103 - Symmetry in basic physical laws. |
Publication Detail:
|
Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Allergy Volume: 64 ISSN: 1398-9995 ISO Abbreviation: Allergy Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-09-23 Completed Date: 2010-01-06 Revised Date: 2011-05-05 |
Medline Journal Info:
|
Nlm Unique ID: 7804028 Medline TA: Allergy Country: Denmark |
Other Details:
|
Languages: eng Pagination: 1427-43 Citation Subset: IM |
Affiliation:
|
Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anti-Allergic Agents* / administration & dosage, therapeutic use Child Child, Preschool Drug Administration Schedule Female Histamine H1 Antagonists, Non-Sedating* / administration & dosage, therapeutic use Humans Infant Male Pregnancy Quality of Life Treatment Outcome Urticaria / diagnosis, drug therapy*, therapy* |
| Grant Support | |
ID/Acronym/Agency:
|
L30 AI062312-03/AI/NIAID NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Allergic Agents; 0/Histamine H1 Antagonists, Non-Sedating |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.
Next Document: Regular vs prn nebulized treatment in wheeze preschool children.